Popular Articles

CNN Profiles 'Generation' Of Teenagers, Young Adults Born With HIV
CNN looks at the lives of teenagers and young adults who were born with HIV before advancements in antiretroviral drugs in the 1990s helped prevent mother-to-child transmission. According to CNN, these children "have defied initial expectations" and "danced at their high school proms, walked on stage to receive their diplomas and even experienced the birth of their children." The article profiles a group of HIV-positive teenagers and young adults in Miami called the Kool Kids. The group was established in 1995 to help children living with HIV cope with the "usual complications of adolescence" and also the "broken families, medical complications and fights for acceptance" that exist as a result of their HIV (Park, CNN, 6/22).
new payday loan lenders
BioVex To Report Phase I/II Clinical Trial Results For The Front Line Treatment Of Head And Neck Cancer
BioVex Inc, a company developing next generation biologics for the treatment and prevention of cancer and infectious disease, announced that the results from a Phase I/II combination study in previously untreated patients with head and neck cancer will be presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place May 29, 2009 - June 2, 2009 in Orlando, FL.
News of the day
Vatican's Approach To Obama On Abortion Rights Contrasts With That Of U.S. Bishops
National Partnership for Women & FamiliesDuring his visit to the Vatican on Friday, President Obama is likely to receive a warmer welcome from Pope Benedict XVI than he has from some U.S. Roman Catholic bishops, experts on the church say, the New York Times reports. The meeting will occur after the conclusion of the Group of Eight industrialized nations summit in Italy and three days after the pope released an encyclical, "Caritas in Veritate," updating the church"s social teaching on the global economy.Early in Obama"s administration, U.S. Catholic bishops "set an adversarial tone" over Obama"s views on abortion rights, contraception and embryonic stem cell research, the Times reports. Although the pope also disagrees with Obama on those issues, he and Obama both recognize an opportunity to come together on international issues like climate change, poverty, nuclear nonproliferation and immigration reform, according to the Times. In a session with reporters from Catholic publications last week, Obama said the church has "always been a powerful moral compass" on questions of social justice. He also said that U.S. bishops "have a profound influence" and that he would take his critics" opinions seriously.The Vatican has often taken a much softer approach than the U.S. bishops in its reactions to Obama"s abortion-rights policies, according to the Times. The president of the U.S. Conference of Catholic Bishops said in a letter issued after the election that "aggressive pro-abortion policies" would "be seen by many as an attack on the free exercise of their religion." In contrast, the Vatican sent Obama a telegram of congratulations immediately after his election, which experts say is "a highly unusual gesture" because the Vatican usually waits until inauguration, the Times reports.More recently, several U.S. bishops denounced the University of Notre Dame for inviting Obama to give the spring commencement address and receive an honorary degree. The Vatican"s newspaper ran a "markedly positive" article about Obama"s speech in reaction to the controversy, according to the Times. Some Vatican officials have also expressed support for Obama"s "common ground" approach to reducing the need for abortion, whereas some U.S. bishops and antiabortion-rights leaders have reacted with "suspicion and disdain," the Times reports (Goodstein, New York Times, 7/10).According to John Allen, a Vatican correspondent for the National Catholic Reporter, cultural differences between U.S. and European Catholic views on abortion rights help explain their contrasting approaches to the issue. Allen said that abortion is usually "the defining social and political issue" in the U.S., and that "everything else, in a way, takes second place." In Europe "that has never been the case," and "even the most conservative Catholics in Europe ... don"t evaluate political leaders exclusively through the basis of their positions on abortion and other so-called life issues," Allen said (Poggioli, "Morning Edition," NPR, 7/10).The Vatican and the U.S. bishops also have different approaches to working with governments, according to the Rev. Drew Christensen, editor-in-chief of the national Jesuit weekly magazine America. Christensen, who formerly worked for the church in international relations, said that some Obama critics "think you have to be at war, and the pope is saying, there"s a different way to proceed here and it"s very essential to the church"s approach, in that what you want is consensus." Christensen added that the pope is "trying to engage America"s capacity for good in the world at a time when it"s really critical" (New York Times, 7/10).
Health Insurance

Preventing Breast Cancer The Focus Of 2009-2010 Susan G. Komen For The Cure Promise Grants

One of the most important challenges in the cancer community today is whether people can, in fact, prevent their own cancers. Susan G. Komen for the Cure® is announcing millions of dollars in long-term grant funding to find out. The world"s leading breast cancer organization is now asking the scientific community for proposals for long-term research grants - some as large as $5 million - to study everything from the role of natural products to diets to breast cancer vaccines. "Prevention is a very hot issue these days, but clear enough scientific evidence to say that this diet, that behavior, or the elimination of this environmental agent significantly reduces your risk of breast cancer doesn"t yet exist. And we certainly don"t have a vaccine to prevent breast cancer," said Hala Moddelmog, Komen"s president and CEO. "Since our mission is to end breast cancer forever, we consider prevention and vaccine research absolutely critical, and we"re willing to invest significant sums to get these answers." The research will be funded through Komen"s unique Promise Grants: multi-year, multi-million dollar projects geared to answer the toughest questions in breast cancer science today. Introduced in 2008, Promise Grants require collaboration across a wide range of disciplines - scientists, medical professionals, caregivers, public health specialists and advocates - who normally may not work together. These teams conduct research with the highest potential to deliver treatments for breast cancer more quickly and for this new Promise Grant to find ways to prevent breast cancer. "Komen"s mission has always been to find cures for breast cancer, which to this point has involved hundreds of millions of dollars and three decades of research into understanding the disease and developing treatments that are saving lives," said Diana Rowden, vice president of Health Sciences. "It"s absolutely critical for us to work on strategies to prevent breast cancer entirely, or at least pinpoint the environmental and lifestyle issues that may contribute to breast cancer. We know this research will get us closer." Komen"s $450 million in research funding since its founding in 1982 has touched every major development in breast cancer treatments during the past 27 years. In the last three years alone, Komen has invested more than $230 million in research projects in the U.S. and internationally. About the Request for Applications These upcoming grants will run from three to five years with amounts up to $5 million. Applications for the grants will be accepted until July 15, 2009. In order to be considered for funding, researchers must be able to prove their prevention approach is worthwhile and must start testing it on humans before the five-year grant expires. The grants are aimed especially at novel approaches to breast cancer prevention. Grant applicants should also describe how their findings from early phase trials will lead to more advanced testing and ultimately to a prevention for breast cancer. Research designed to prevent breast cancer from recurring will not be considered for the 2009-2010 Promise Grants, but these grants may be used to support drug formulation, dietary and/or behavioral formulas, or previously untested novel methods. Komen for the Cure will be accepting applications from U.S. and international researchers but they must work for nonprofit institutions or organizations. The grant allows for the involvement of industry partners, however they can not be reimbursed for any fee or profit. Interested applicants can visit http://ww5.komen.org/researchgrants/grantprograms.html for details. The anticipated start of funding for these prevention Promise Grants is May 2010. Susan G. Komen for the Cure®


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):